"Istituto Ortopedico"

During the past decade, Istituto Ortopedico Rizzoli conducted 123 clinical trials. In the 10-year time frame, 123 clinical trials started and 17 clinical trials were completed, i.e. on average, 13.8% percent of trials that started reached the finish line to date. In the past 5 years, 71 clinical trials started and 14 clinical trials were completed. i.e. 19.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Istituto Ortopedico Rizzoli" #1 sponsor was "Istituto Ortopedico Rizzoli" with 88 trials, followed by "Italian Sarcoma Group" with 6 trials sponsored, "Luca Sangiorgi" with 4 trials sponsored, "Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna" with 3 trials sponsored and "Grupo Espanol de Investigacion en Sarcomas" with 3 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Istituto Ortopedico Rizzoli" #1 collaborator was "University of Bologna" with 5 trials as a collaborator, "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Amgen" with 2 trials as a collaborator, "Associazione Italiana Ematologia Oncologia Pediatrica" with 2 trials as a collaborator and "European Commission" with 2 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Istituto Ortopedico Rizzoli" are "Knee Osteoarthritis" (7 trials), "Osteosarcoma" (6 trials), "Hip Osteoarthritis" (5 trials), "Osteoarthritis" (5 trials) and "Osteoarthritis, Knee" (3 trials). Many other conditions were trialed in "Istituto Ortopedico Rizzoli" in a lesser frequency.

Most popular intervention types in "Istituto Ortopedico Rizzoli" are "Procedure" (39 trials), "Drug" (35 trials), "Other" (35 trials), "Device" (18 trials) and "Diagnostic Test" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Ifosfamide" (4 trials), "Trabectedin" (3 trials), "Dacarbazine" (2 trials) and "Doxorubicin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Istituto Ortopedico Rizzoli" are 144 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Istituto Ortopedico Rizzoli". undefined are not yet recruiting, 53 are recruiting, 11 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 59 completed trials in Istituto Ortopedico Rizzoli, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Istituto Ortopedico Rizzoli, 5 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 61 trials that are defined as “Not Applicable".

Istituto Ortopedico Rizzoli has several departments that took part in Clinical trials: "Rizzoli Orthopaedic Institute" - 21 trials, "Istituti Ortopedici Rizzoli - Unit of chemotherapy of Muscoloskeletal Tumors" - 12 trials, "II Orthopaedic Clinic, Rizzoli Orthopaedic Institute" - 3 trials, "Chirurgia Protesica e dei Reimpianti di Anca e Ginocchio, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy" - 2 trials, "Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli" - 2 trials, "Istituto Ortopedico Rizzoli - Laboratorio Tecnologia Medica" - 2 trials